Novel Antisense Oligonucleotides Targeting TGF-β Inhibit in Vivo Scarring and Improve Surgical Outcome

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301865
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cell-Penetrating Peptides Selectively Targeting SMAD3 Inhibit Profibrotic TGF-β Signaling

Journal of Clinical Investigation
Medicine
2017English

Targeted Delivery of Antisense Oligonucleotides to Pancreatic Β-Cells

Science advances
Multidisciplinary
2018English

Abrogation of TGF-β by Antisense Oligonucleotides Modulates Expression of VEGF and Increases Angiogenic Potential in Isolated Fibroblasts From Radiated Skin

International Journal of Molecular Medicine
MedicineGenetics
1998English

PPARγ Agonists Inhibit TGF-β-PKA Signaling in Glomerulosclerosis

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

In Vivo Suppression of the Renal Na+/Pi Cotransporter by Antisense Oligonucleotides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Targeting Stat3 and Smad7 to Restore TGF-β Cytostatic Regulation of Tumor Cells in Vitro and in Vivo

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Novel Β-Carbolines Inhibit WNT/Β-Catenin Signaling

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Targeting Translation Termination Machinery With Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Antisense Oligonucleotides From the Stage-Specific Myeloid Zinc Finger Gene MZF-1 Inhibit Granulopoiesis in Vitro

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy